Lyell Wealth Management LP Has $3.02 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Lyell Wealth Management LP grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the fourth quarter, Holdings Channel.com reports. The firm owned 22,872 shares of the financial services provider’s stock after buying an additional 598 shares during the period. Lyell Wealth Management LP’s holdings in iShares Biotechnology ETF were worth $3,024,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in IBB. BNP Paribas Financial Markets grew its stake in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares in the last quarter. Commerce Bank boosted its position in iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after purchasing an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its position in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Main Management ETF Advisors LLC boosted its position in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after purchasing an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $18,476,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.4 %

Shares of iShares Biotechnology ETF stock opened at $137.11 on Wednesday. The stock has a 50 day moving average price of $135.55 and a two-hundred day moving average price of $140.81. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.